Men and women differ in their diurnal expression of monocyte peroxisome proliferator-activated receptor-α in the fed but not in the fasted state

被引:11
|
作者
Wege, Nicole [1 ]
Schutkowski, Alexandra [1 ]
Boenn, Markus [2 ,4 ]
Bialek, Joanna [1 ]
Schlitt, Axel [3 ,5 ]
Noack, Frank [3 ]
Grosse, Ivo [2 ,6 ]
Stangl, Gabriele I. [1 ]
机构
[1] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06120 Halle, Germany
[2] Univ Halle Wittenberg, Inst Comp Sci, D-06120 Halle, Germany
[3] Univ Halle Wittenberg, Univ Clin Halle Saale, D-06120 Halle, Germany
[4] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany
[5] Paracelsus Harz Clin Bad Suderode, Quedlinburg, Germany
[6] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany
关键词
caloric intake; nuclear receptor; circadian pacemaker; PPAR-ALPHA; THERAPEUTIC TARGET; SEXUAL SELECTION; ANGIOGENESIS; INVOLVEMENT; METABOLISM; MUSCLE; CLOCK; MODEL;
D O I
10.1096/fj.14-267575
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peroxisome proliferator-activated receptor-alpha (PPAR alpha) plays a pivotal role in regulating metabolic response to fasting and is an inhibitor of inflammatory pathways in immune cells. It represents a therapeutic target for treatment of several diseases, mainly hyperlipidemia. To shed light on PPAR alpha expression changes in response to fasting, young healthy male and female volunteers were fed or fasted for 24 hours. Monocytes were analyzed every 2 hours to compile both profiles of mRNA and protein expression of PPAR alpha and its interactive partner, the circadian pacemaker brain and muscle aryl hydrocarbon receptor nuclear translocator like-1 (BMAL1). We found that women change their diurnal expression profiles of PPAR alpha and BMAL1 when switching from the fed to the fasted state, whereas men do not. Interestingly, the PPAR alpha and BMAL1 profiles of men and women in the fed state are different, whereas the profiles in the fasted state are virtually identical. The finding of diametrically opposite responses of male and female PPAR alpha expression in the fed state might have practical implication in human medicine as PPAR alpha activators like fibrates are used for the therapy of chronic lymphocytic leukemia, microvascular complications in diabetes, and kidney diseases.
引用
收藏
页码:2905 / 2911
页数:7
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor δ regulates mitofusin 2 expression in the heart
    Li, Yuquan
    Yin, Ran
    Liu, Jian
    Wang, Peiyong
    Wu, Sijie
    Luo, Jinwen
    Zhelyabovska, Olga
    Yang, Qinglin
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 46 (06) : 876 - 882
  • [42] Peroxisome proliferator-activated receptor-α and retinoid X receptor agonists inhibit inflammatory responses of astrocytes
    Xu, Jihong
    Chavis, Janet A.
    Racke, Michael K.
    Drew, Paul D.
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 176 (1-2) : 95 - 105
  • [43] Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor γ
    Chambrier, C
    Bastard, JP
    Rieusset, J
    Chevillotte, E
    Bonnefont-Rousselot, D
    Therond, P
    Hainque, B
    Riou, JP
    Laville, M
    Vidal, H
    OBESITY RESEARCH, 2002, 10 (06): : 518 - 525
  • [44] Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy
    Mansoor, Hassan
    Lee, Isabelle Xin Yu
    Lin, Molly Tzu-Yu
    Ang, Heng Pei
    Xue, Yao Cong
    Krishaa, L.
    Patil, Moushmi
    Koh, Siew-Kwan
    Tan, Hong Chang
    Zhou, Lei
    Liu, Yu-Chi
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [45] Cellular and molecular consequences of peroxisome proliferator-activated receptor-γ activation in ovarian cancer cells
    Vignati, Sara
    Albertini, Veronica
    Rinaldi, Andrea
    Kwee, Ivo
    Riva, Cristina
    Oldrini, Rita
    Capella, Carlo
    Bertoni, Francesco
    Carbone, Giuseppina M.
    Catapano, Carlo V.
    NEOPLASIA, 2006, 8 (10): : 851 - U34
  • [46] Peroxisome Proliferator-Activated Receptor-α Control of Lipid and Glucose Metabolism in Human White Adipocytes
    Ribet, Carole
    Montastier, Emilie
    Valle, Carine
    Bezaire, Veronic
    Mazzucotelli, Anne
    Mairal, Aline
    Viguerie, Nathalie
    Langin, Dominique
    ENDOCRINOLOGY, 2010, 151 (01) : 123 - 133
  • [47] Hepatic sirtuin 1 is dispensable for fibrate- induced peroxisome proliferator-activated receptor-α function in vivo
    Bonzo, Jessica A.
    Brocker, Chad
    Jiang, Changtao
    Wang, Rui-Hong
    Deng, Chu-Xia
    Gonzalez, Frank J.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2014, 306 (07): : E824 - E837
  • [48] Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging
    De Silva, T. Michael
    Li, Ying
    Kinzenbaw, Dale A.
    Sigmund, Curt D.
    Faraci, Frank M.
    HYPERTENSION, 2018, 72 (01) : 227 - 234
  • [49] Transcriptional Modulation of the Immune Response by Peroxisome Proliferator-Activated Receptor-α Agonists in Autoimmune Disease
    Gocke, Anne R.
    Hussain, Rehana Z.
    Yang, Yuhong
    Peng, Haiyan
    Weiner, Jeffrey
    Ben, Li-Hong
    Drew, Paul D.
    Stuve, Olaf
    Lovett-Racke, Amy E.
    Racke, Michael K.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (07) : 4479 - 4487
  • [50] Regulation of Peroxisome Proliferator-Activated Receptor-β/δ by the APC/β-CATENIN Pathway and Nonsteroidal Antiinflammatory Drugs
    Foreman, Jennifer E.
    Sorg, Joseph M.
    McGinnis, Kathleen S.
    Rigas, Basil
    Williams, Jennie L.
    Clapper, Margie L.
    Gonzalez, Frank J.
    Peters, Jeffrey M.
    MOLECULAR CARCINOGENESIS, 2009, 48 (10) : 942 - 952